logo
Select company
Select metric
$ -95.04MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
8
Sector
20
Industry
30
History
29
$ 3.45Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 3.13M$ -98.17M$ -95.04M
3/31/2025$ 3.15M$ -97.4M$ -94.25M
12/31/2024$ 3.68M$ -79.5M$ -75.81M
9/30/2024$ 3.82M$ -57.36M$ -53.53M
6/30/2024$ 3.59M$ -59.2M$ -55.61M
3/31/2024$ 3.53M$ -57.8M$ -54.27M
12/31/2023$ 2.59M$ -73.79M$ -71.2M
9/30/2023$ 2.17M$ -94.29M$ -92.12M
6/30/2023$ 2M$ -98.92M$ -96.92M
3/31/2023$ 1.78M$ -108.58M$ -106.8M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA stands at $ -12.41M.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average EBITDA has been $ -79.19M.
  • The median EBITDA for PYXIS ONCOLOGY INC during this period was $ -86.45M
  • PYXIS ONCOLOGY INC reached its highest EBITDA over the past 5 years at $ -12.41M.
  • The lowest EBITDA recorded by PYXIS ONCOLOGY INC in the same timeframe $ -118.88M

PYXIS ONCOLOGY INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
NTRB : NUTRIBAND INC $ -9.95MALGS : ALIGOS THERAPEUTICS INC $ -58.76MSTTK : SHATTUCK LABS INC $ -57.29MORMP : ORAMED PHARMACEUTICALS INC $ -34.88MCAMP : CAMP4 THERAPEUTICS CORP $ -48.23MARMP : ARMATA PHARMACEUTICALS INC $ -10.66MDTIL : PRECISION BIOSCIENCES INC $ -73.73MNRXS : NEURAXIS INC $ -7.03MCBUS : CIBUS INC $ -234.61MABVC : ABVC BIOPHARMA INC $ -2.42M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PYXIS ONCOLOGY INC is calculated as follows: EBIT [ $ -12.83M ] + DepAmor [ $ 413K ]
(=) EBITDA [ $ -12.41M ]

PYXS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -118.88M

Minimum

Dec 31, 2022

$ -12.41M

Maximum

Dec 31, 2020

$ -79.19M

Average

$ -86.45M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M